Unfinished, history of asthma

Inconclusa historia del asma

Published 2018-11-13

Open | Download
PDF (Spanish) FLIP
Issue
Vol. 30 No. 1 (2018)
Section
Topics review
How to Cite
Unfinished, history of asthma.
rev. colomb. neumol. [Internet]. 2018 Nov. 13 [cited 2024 Dec. 22];30(1):18-2. Disponible en: https://doi.org/10.30789/rcneumologia.v30.n1.2018.298
DOI

https://doi.org/10.30789/rcneumologia.v30.n1.2018.298
Dimensions
PlumX
license

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Gustavo Adolfo Gómez Correa
    Show authors biography
    his review describes the etiology and nature of asthma in the historical context, the pathology and pathophysiology in time, and how the asthma therapy concept has been developed. Since ancient times, asthma has been recognized by many cultures, including Chinese, Hebrew, Greek, and Roman. The Greek physician Hippocrates (460-377 BC) was one of the first to describe it, although the term was used to refer to a symptom and not to a disease. The major contribution to understanding asthma in the nineteenth century was made by Henry Hyde Salter (1823–1871). He proposed its subdivision into intrinsic and extrinsic asthma based on the mechanism and nature of various stimuli. William Osler (1849-1919) described the correlation between the various stimuli causing paroxysmal disorder of the airways in asthma.

    Article visits 2060 | PDF visits 7953

    Downloads

    Download data is not yet available.
    1. A controlled trial of inhaled corticosteroids in patients receiving Prednisone tablets for asthma. Br J Dis Chest. 1976;70(2):95-103.
    2. Alexander HL. A historical account of death from asthma. J Allergy. 1963;34:305-22.
    3. Jackson M. Allergy: the history of a modern malady. Londres: Reaktion Books Ltd.; 2006.
    4. Jackson M. Asthma: the biography. Nueva York: Oxford University Press; 2009.
    5. Bergmann KC. Asthma. Chem Immunol Allergy. 2014;100:69-80.
    6. Diamant Z, Boot JD, Virchow JC. Summing up 100 years of asthma. Respir Med. 2007;101(3):378-88.
    7. Cserháti E. The history of bronchial asthma from the ancient times till the Middle Ages. Acta Physiol Hung. 2004;91(3-4):243-61.
    8. Cserháti E. The history of bronchial asthma from the Renaissance till the beginning of the twentieth century. Acta Physiol Hung. 2005;92(2):181-92.
    9. Ellul-Micalle R. Asthma: a look at the past. Br J Dis Chest. 1976;70(2):112-6.
    10. Falliers CJ. The origins of asthma and its clinical “cures”. J Asthma. 1982;19(4):227-8.
    11. Marketos SG, Ballas CN. Bronchial asthma in the medical literature of Greek antiquity. J Asthma. 1982;19(4):263-9.
    12. Cohen SG. Asthma in antiquity, the Ebers Papyrus. Allergy Proc. 1992;13(3):147-54.
    13. Cohen SG. Asthma and obesity: an archival addendum. J Allergy Clin Immunol. 2009;123(1):265-6; author reply 266.
    14. Cohen SG. Blocking asthmatic progression and chronicity in the pre-corticosteroid era. J Allergy Clin Immunol. 2008;121(3):787-90.
    15. Cohen SG. Asthma and athletics. J Allergy Clin Immunol. 2008;122(2):435-9, 439.e1-3.
    16. McFadden ER Jr. A century of asthma. Am J Respir Crit Care Med. 2005;170(3):215-21.
    17. Osler W. Bronchial asthma. Principles and practice of medicine. Nueva York: D. Appleton & Co.; 1892.
    18. Chu EK, Drazen JM. Asthma: a one hundred years of treatment and onward. Am J Respir Crit Care Med. 2005;171(11):1202-8.
    19. Floyer JS. A treatise of the asthma. Divided into four parts printed for Richard Wilkin at St. Pauls’ Churchyard, London. 1698.
    20. 20. Murtagh P. Asma: ayer y hoy. Arch Argent Pediatr. 009;107(2):146-51.
    21. Neale AV. Some thoughts and experiments on respiration and on asthma, with special reference to Henry Hyde Salter. Med Hist. 1963;7:247-57.
    22. Persson CGA. On the medical history of xanthines and other remedies for asthma: a tribute to HH Salter. Thorax. 1985;40(12):881-6.
    23. Sakula A. Henry Hyde Salter (1823-71): a biographical sketch. Thorax. 1985;40(12):887-8.
    24. Salter HH. On asthma: its pathology and treatment. Londres: John Churchill; 1860.
    25. Sakula A. Charcot-Leyden crystals and Curschmann spirals in asthmatic sputum. Thorax. 1986;41(7):503-7.
    26. Kay AB. The early history of the eosinophil. Clin Exp Allergy. 2015;45(3):575-82.
    27. Schwartz RS. Paul Ehrlich’s magic bullets. N Engl J Med. 2004;350(11):1079-80.
    28. Ring J, Gutermuth J. 100 years of hyposensitization: history of allergen-specific immunotherapy (ASIT). Allergy. 2011;66(6):713-24.
    29. Fowler JK, Godlee RJ. Asthma. En: The diseases of the lungs. Nueva York: Longmans, Green, and Company; 1898. p. 183-94.
    30. Holgate ST. Lessons learnt from the epidemic of asthma. QJM. 2004;97(5):247-57.
    31. Holgate ST. Asthma: a simple concept but in reality a complex disease. Eur J Clin Invest. 2011;41(12):1339-52.
    32. Huber HL, Koessler KK. The pathology of bronchial asthma. Arch Intern Med. 1922;30(6): 689-760.
    33. Dunnill MS. The pathology of asthma, with special reference to changes in the bronchial mucosa. J Clin Pathol. 1960;13:27-33.
    34. Dale HH, Laidlaw PP. The physiological action of β-iminazolylethylamine. J Physiol. 1911;41(5):318-44.
    35. Curry JJ. The action of histamine on the respiratory tract in normal and asthmatic subjects. J Clin Invest. 1946;25(6):785-91.
    36. Riley J, West GB. Histamine and tissue mast cells. J Physiol. 1953;117(4):72P-73P.
    37. Ishizaka K, Ishizaka T, Hornbrook MM. Physico-chemical properties of human reaginic antibody. IV. Presence of a unique immunoglobulin as a carrier of reaginic activity. J Immunol. 1966;97(1):75-85.
    38. Voorhorst R, Spieksma F, Varekamp H, et al. The house-dust mite (Dermatophagoides pteronyssinus) and the allergens it produces. Identity with the house-dust allergen. J Allergy. 1967;39(6):325-39.
    39. Ellul-Micallef R. Airway smooth muscle in health and in asthma. Br J Dis Chest. 1973;67(2):107-13.
    40. Laitinen LA, Heino M, Laitinen A, Kava T. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis. 1985;131(4):599-606.
    41. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammations. Science. 1983;220(4597):568-75.
    42. Weiss JW, Drazen JM, Coles N, McFadden ER Jr, Weller PF, Corey EJ, et al. Bronchoconstrictor effects of leukotriene C in humans. Science. 1982;216(4542):196-8.
    43. Brown OH. Treatment of asthma. En: Brown OH. Asthma: presenting an exposition of the non-passive expiration theory. St Louis: C.V. Mosby; 1917. p. 265-88.
    44. Anderson PJ. History of aerosol therapy. Liquid nebulization to MDIs to DPIs. Respir Care. 2005;50(9):1139-50.
    45. Jackson M. “Divine stramonium”: the rise and fall of smoking for asthma. Med Hist. 2010;54(2):171-94.
    46. Herrmann G, Aynesworth MB. Successful treatment of persistent extreme dyspnea “status asthmaticus”: use of theophylline ethylene diamine (aminophylline, USP) intravenously. J Lab Clin Med. 1937;23:135-48.
    47. Siegel SC. History of asthma deaths from antiquity. J Allergy Clin Immunol. 1987;80(3 Pt 2):458-62.
    48. Stewart TG, Gibson GA. Asthma. En: Stedman TL (editor). Twentieth century practice: an international encyclopedia of modern medical science by leading authorities of Europe and America. Volumen VI. Nueva York: William Wood and Co; 1896. p. 585-617.
    49. Gross MJ. Sch 1000: a new anticholinergic bronchodilator. Am Rev Respir Dis. 1975;112(6):823-8.
    50. Sanders M. Inhalation therapy: an historical review. Prim Care Respir J. 2007;2(16):71-81.
    51. Solis-Cohen S. The use of adrenal substance in the treatment of asthma. JAMA 1900;34:1164-6.
    52. Solis-Cohen S. The use of adrenal substance in the treatment of asthma. 1900. J Asthma. 1990;27(6):401-6.
    53. Barger G, Dale HH. Chemical structure and sympathomimetic action of amines. J Physiol. 1910;41(1-2):19-59.
    54. Hui KK, Barolet-Garcia C. A patient with asthma seeks medical advice. N Engl J Med. 2012;366(18):1741-2; author reply 1742.
    55. Kagouridis K. A patient with asthma seeks medical advice. N Engl J Med. 2012;366(18):1740; author reply 1742.
    56. O’Sullivan BP, Zwerdling RG, Kremer T. A patient with asthma seeks medical advice. N Engl J Med. 2012;366(18):1740; author reply 1742.
    57. Simons SM. A patient with asthma seeks medical advice. N Engl J Med. 2012;366(18):1741; author reply 1742.
    58. von Mutius E, Drazen JM. A patient with asthma seeks medical advice in 1828, 1928, and 2012. N Engl J Med. 2012;366(9):827-34.
    59. Melland B. The treatment of spasmodic asthma by the hypodermic injection of adrenalin. Lancet. 1910;i:1407-11.
    60. Pérez-Martín J. Cronología de los medicamentos para el asma. Rev Alerg Mex. 1999;46(6):152-4.
    61. National Library of Medicine. National Institutes of Health. U.S. Department of Health and Human Services. Breathe of life. Washington.
    62. Gay LN, Long JW. Clinical evaluation of isopropyl-epine- phrine in management of bronchial asthma. J Am Med Assoc. 1949;139(7):452-7.
    63. Persson CG. In vivo veritas: the continuing importance of discoveries in complex biosystems. Thorax. 1996;51(4):441-3.
    64. Persson CG. Astute observers discover anti-asthma drugs. Pharmacol Toxicol. 1995;77 Suppl 3:7-15.
    65. Waldeck B. Beta-adrenoceptor agonists and asthma—100 years of development. Eur J Pharmacol. 2002;445(1-2):1-12.
    66. Ahlquist RP. A study of the adrenotropic receptors. Am J Physiol. 1948;153(3):586-600.
    67. Rau JL. Inhaled adrenergic bronchodilators: historical development and clinical application. Respir Care. 2000;45(7):854-63.
    68. Rossing TH, Fanta CH, Goldstein DH, Snapper JR, McFadden ER Jr. Emergency therapy of asthma: comparison of the acute effects of parenteral and inhaled sympathomimetics and infused aminophylline. Am Rev Respir Dis. 1980;122(3):365-71.
    69. Barnes PJ, Breckenridge A. David Jack (1924-2011) who revolutionised the treatment of asthma. Thorax. 2012;67(3):266-7.
    70. Page C, Humphrey P. Sir David Jack: an extraordinary drug discoverer and developer. Br J Clin Pharmacol. 2012;75(5):1213-8.
    71. Cromptom G. A brief history of inhaled asthma therapy over the last fifty years. Prim Care Respir J. 2006;2(15):326-31.
    72. Tattersfield AE. Current issues with beta2-adrenoceptor agonists: historical background. Clin Rev Allergy Immunol. 2006;31(2-3):107-18.
    73. Schwartz E. Oral cortisone therapy in intractable bronchial asthma. J Am Med Assoc. 1951;147(18):1734-7.
    74. McCombs RP. Serial courses of corticotrophin or cortisone in chronic bronchial asthma. N Engl J Med. 1952;247(1):1-6.
    75. Brown HM. How the first effective inhaled corticosteroid was almost discarded as useless. Ann Allergy Asthma Immunol. 2007;98(6):602-3.
    76. Brown HM, Storey G, George WH. Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma. Br Med J. 1972;1(5800):585-90.
    77. Clark TJ. Effect of beclomethasone dipropionate delivered by aerosol in patients with asthma. Lancet. 1972;1(7765):1361-4.
    78. Partridge MR. Asthma 1987-2007. What have we achieved and what are the persisting challenges? Prim Care Respir J. 2007;2(16):145-8.
    79. Inhaled corticosteroids compared with oral prednisone in patients starting long-term corticosteroid therapy for asthma. A controlled trial by the British Thoracic and Tuberculosis Association. Lancet. 1975;2(7933):469-73.
    80. Davies G, Thomas P, Broder I, Mintz S, Silverman F, Leznoff A, et al. Steroid-dependent asthma treated with inhaled beclomethasone diproprionate. Ann Intern Med. 1977;86:549-53.
    81. Wyatt R, Waschek J, Weinberger M, Sherman B. Effects of inhaled beclomethasone dipropionate and alternate-day prednisone on pituitary adrenal function in children with chronic asthma. N Engl J Med. 1978;299(25):1387-92.
    82. O`Byrne PM, Nair P, Sterk PJ. In memoriam: Frederick E Hargreave (1938-2011). Thorax 2011;66(12):1101-2.
    83. Persson CG. Glucocorticoids for asthma--early contributions. Pulm Pharmacol. 1989;2(3):163-6.
    84. Raji MA. The nervous system as potential targets for asthma treatments: lessons learned from a centennial history of asthma research. Am J Respir Cell Mol Biol. 2005;33(2):211.
    85. Walter M. A Centennial History of Research on Asthma Pathogenesis. Am J Respir Cell Mol Biol. 2005;(32):483-9.
    86. Orr TS. Mast cells and allergic asthma. Br J Dis Chest. 1973;67(2):87-106.
    87. Edwards AM. Gleb von Anrep. J R Soc Med. 1998;91(6):345.
    88. Yentis SM. Minds and hearts: themes in the life of Gleb von Anrep. J R Soc Med. 1998;91(4):209-12.
    89. Edwards AM, Howell JB. The chromones: history, chemistry and clinical development. A tribute to the work of Dr R. E. C. Altounyan. Clin Exp Allergy. 2000;30(6):756-74.
    90. Howell JB, Altounyan RE. A double-blind trial of disodium cromoglycate in the treatment of allergic bronchial asthma. Lancet. 1967;2(7515):539-42.
    91. Cespedes B, Restrepo A, Restrepo B, Vieira T. Índice de la literatura médica colombiana 1890-1960. Bogotá: ASCOFAME; Ediciones Tercer Mundo; 1964.
    92. Arango MS. Dos casos de asma tratados por autoterapia. Rev Med Bogotá. 1918;36(429/432):100-65.
    93. Arbeláez H. El asma infantil y su tratamiento por los rayos ul- travioleta. Medellín: Clínica Gil. Medellín; 1926. p. 373-376.
    94. Barrios H. Estados asmatiformes en el lactante. Rev Med Cir Barranquilla. 1949;16(10):13-8.
    95. Camacho A. Asmas. Diagnóstico. Etiología, patogenia y tratamiento. Medicina. Bogota. 1939;1(5):131-9.
    96. Castro G. Algunas consideraciones sobre el asma bronquial. Medicina y Ciencias Afines. Bogotá. 1958;9(1):1-26.
    97. Cuba TM. Asma no es ninguna entidad nosológica. Cartagena: Clínica Vargas; 1953. p. 36-41.
    98. Jordán R. Estudio del cuajaní y su aplicación en el asma esencial. Medellín: Labor; 1927. p. 121-7.
    99. Meluk T. El asma bronquial; aspectos psicosomáticos. El Médico. Bogotá. 1958;2(10):9-16.
    100. Méndez M. Algo sobre el tratamiento del asma esencial por las inyecciones de adrenalina. Repertorio de Medicina y Cirugía. Bogotá. 1917;8(12):554-8.
    101. Restrepo JM. Síndrome asmático y factores psíquicos. Antioquia Médica. Medellín. 1957;7:487-95.
    102. Restrepo N. Asma y asmáticos. Revista Facultad de Medicina. Bogotá. 1943;11(11):635-44.
    103. Rodríguez E. Terapéutica etiopatológica del asma. Orientaciones Médicas. Medellín. 1954;3:263-5.
    104. Ruiz G. La dieta del asmático. Revista de Medicina y Cirugía. Barranquilla. 1937;4(3):10-21.
    105. Trujillo C. El determinismo de las crisis de asma anafiláctico y coloidoclásico. Repertorio de Medicina y Cirugía. Bogotá. 1924;15(10):529-36.
    106. Valero C. El asma y sus tratamientos. Medicina y Cirugía. Bogotá. 1942;6(5):207-14.
    107. Sitios web
    108. • http://www.inhalatorium.com/
    109. • https://farmaciamuseodayanueva.wordpress.com/respiratorio/
    110. • http://hardluckasthma.blogspot.com.co/p/asthma-history.html
    Tutorials

    Autors:

    How send article?

    Evaluator pair

    How to evaluate an article?

    Information

    Journal history

    Keywords

    Directories and indexes

    Sponsors

    Support + Info Here

    Google Scholar profile

    Most read in the last 30 days

    Current Issue

    QR code

    Sistema OJS 3.4.0.7 - Metabiblioteca |